Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I. in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
Fox Chase Cancer Center /Inc/
Search grants from Fox Chase Cancer Center /Inc/
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Ohio State University Center for Clinical and Translational Science
Structure and Cell-Wall Targeting of the Staphylolytic Enzyme Lysostaphin
CDI-Type II: Collaborative Research: A Paradigm Shift in Ecosystem and Environmental Modeling: An Integrated Stochastic, Deterministic, and Machine Learning Approach
A New Theoretical and Algorithmic Framework for RTL Datapath Verification using Polynomial Algebra over Finite Integer Rings
Research Experiences for Undergraduates in Chemistry at Columbia University
Recently added grants:
Targeting TERT in Melanoma
Flourine-18 labeled MDM2 antagonists for PET imaging
Multiscale Modeling to Optimize Inhibition of Oncogenic ERK Pathway Signaling
Role of KAT5 in lung cancer
Psychological and brain mechanisms underlying disparities in opioid and non-opioid pain treatment decisions
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN025120-001
Application #
6994820
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center /Inc/
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
/ Fox Chase Cancer Center /Inc/
NIH 2005
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
/ Fox Chase Cancer Center /Inc/
NIH 2004
N01 CN
Phase I. in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
/ Fox Chase Cancer Center /Inc/
Comments
Be the first to comment on this grant